Dynacirc and Hydrochlorothiazide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dynacirc (isradipine) and Hydrochlorothiazide (hydrochlorothiazide). Common drug interactions include renal failure chronic among females and blood creatinine increased among males.

The phase IV clinical study analyzes what interactions people have when they take Dynacirc and Hydrochlorothiazide. It is created by eHealthMe based on reports of 91 people who take the same drugs from the FDA, and is updated regularly.

What is Dynacirc?

Dynacirc has active ingredients of isradipine. eHealthMe is studying from 975 Dynacirc users. Check the latest studies of Dynacirc.

What is Hydrochlorothiazide?

Hydrochlorothiazide has active ingredients of hydrochlorothiazide. It is often used in high blood pressure. eHealthMe is studying from 182,195 Hydrochlorothiazide users. Check the latest studies of Hydrochlorothiazide.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

91 people who take Dynacirc and Hydrochlorothiazide together, and have interactions are studied.

Dynacirc and Hydrochlorothiazide drug interactions.

What are the common drug interactions of Dynacirc and Hydrochlorothiazide, by gender? *:

female:

  1. Renal failure chronic (long lasting kidney dysfunction)
  2. Oedema peripheral (superficial swelling)
  3. Anaemia (lack of blood)
  4. Abdominal pain
  5. Anxiety
  6. Vomiting
  7. Cardiac failure congestive
  8. Renal failure acute (rapid kidney dysfunction)
  9. Diarrhoea
  10. Abdominal pain upper

male:

  1. Blood creatinine increased
  2. Renal failure acute (rapid kidney dysfunction)
  3. Fall
  4. Fatigue (feeling of tiredness)
  5. Syncope (loss of consciousness with an inability to maintain postural tone)
  6. Death
  7. Decreased appetite
  8. Dysphagia (a condition in which swallowing is difficult or painful)
  9. Dyspnoea (difficult or laboured respiration)
  10. Gait disturbance

What are the common drug interactions of Dynacirc and Hydrochlorothiazide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Abnormal weight gain
  2. Adverse reaction
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Cataract (clouding of the lens inside the eye)
  6. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  7. Contusion (a type of hematoma of tissue in which capillaries)
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. Device expulsion
  10. Drug intolerance (drug sensitivity)

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal pain
  2. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Gastrointestinal pain
  5. Nausea (feeling of having an urge to vomit)
  6. Oedema peripheral (superficial swelling)
  7. Pain in extremity
  8. Vomiting

50-59:

  1. Multiple injuries
  2. Renal failure acute (rapid kidney dysfunction)
  3. Renal failure chronic (long lasting kidney dysfunction)
  4. Visual acuity reduced (reduced clearness of vision)
  5. Headache (pain in head)
  6. Cardiac failure congestive
  7. Acidosis (build-up of carbon dioxide in the blood)
  8. Cataract cortical (it affects outer part of lens)
  9. Impaired work ability
  10. Iron deficiency anaemia

60+:

  1. Asthenia (weakness)
  2. Nausea (feeling of having an urge to vomit)
  3. Bone pain
  4. Decreased appetite
  5. Fall
  6. Gait disturbance
  7. Pneumonia
  8. Abdominal discomfort
  9. Dysuria (painful or difficult urination)
  10. Pain

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 12 people, 13.19%
  2. High Blood Cholesterol: 7 people, 7.69%
  3. Pain: 6 people, 6.59%
  4. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 5 people, 5.49%

* Approximation only. Some reports may have incomplete information.

Do you take Dynacirc and Hydrochlorothiazide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dynacirc and Hydrochlorothiazide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dynacirc:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hydrochlorothiazide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dynacirc and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydrochlorothiazide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on isradipine and hydrochlorothiazide (the active ingredients of Dynacirc and Hydrochlorothiazide, respectively), and Dynacirc and Hydrochlorothiazide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: